Prazopress

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Is Prazopress?

Prazopress is an oral 1 mg Prazosin (immediate-release) tablet from Sun Pharma, supplied in 30-90 tablets. Prazosin was introduced by Pfizer in 1974 as Minipress — the first selective alpha-1 antagonist and the template for the entire alpha-blocker class. Immediate-release prazosin has been largely displaced in hypertension by newer classes, but remains clinically important for PTSD-related nightmares (off-label) and for selective benign prostatic hyperplasia (BPH) cases.

How Prazosin (immediate-release) Works

Prazosin (immediate-release) acts on post-synaptic alpha-1 adrenergic receptors on arterial and venous smooth muscle, and on prostatic/bladder-neck smooth muscle. The downstream effects:

• Arterial and venous vasodilation — blockade of alpha-1 receptors on vascular smooth muscle reduces systemic vascular resistance; venous dilation reduces preload
• Reduced bladder-neck and prostatic smooth-muscle tone — improves urinary flow in BPH (dominant clinical effect for the XL/long-acting forms)
• Improved lipid profile — modest reduction in LDL and triglycerides, small rise in HDL; metabolically distinct from thiazides and beta-blockers
• Improved insulin sensitivity in some studies — an argument for alpha-blockers in hypertensive patients with metabolic syndrome or type 2 diabetes
• No direct effect on renin or electrolytes — potassium, sodium, and creatinine unaffected (contrast with diuretics and RAAS blockers)
• Reflex tachycardia is blunted compared with direct vasodilators (hydralazine, minoxidil) because of some central sympathetic feedback, but still occurs on initiation
• Central alpha-1 blockade in the locus coeruleus is the proposed mechanism for the PTSD-nightmare benefit — reduces noradrenergic hyperarousal during sleep

Approved and Evidence-Based Uses

• PTSD-associated nightmares (off-label; primary modern use), resistant hypertension as add-on, benign prostatic hyperplasia
• PTSD-associated nightmares and sleep disturbance (off-label) — widely used; Raskind RCT evidence
• Benign prostatic hyperplasia — immediate-release prazosin less convenient than XL
• Raynaud phenomenon (off-label; mixed evidence)
• Pheochromocytoma preoperative preparation — phenoxybenzamine is preferred; prazosin is a short-acting alternative in some protocols

Pivotal trial evidence: VA Cooperative Trial (1982) — prazosin comparable to standard antihypertensives in mild-moderate hypertension; established clinical validity. ALLHAT doxazosin arm (2000) — terminated 3 years early due to 25% excess risk of heart failure vs chlorthalidone; interpreted as a class concern for alpha-blockers in HTN. Raskind et al. PTSD trials (2003, 2007, 2013) — prazosin 1-10 mg at bedtime reduced trauma nightmares and improved sleep in combat and civilian PTSD. PACT (2018) — 304 veterans, prazosin did not outperform placebo for PTSD overall, though subgroup analyses remained supportive.

Prazopress Dosage

Primary dose: Hypertension: start 0.5-1 mg at bedtime for the first dose (the “first-dose phenomenon” — see below), then 1 mg 2-3 times daily, titrating to 2-20 mg/day in divided doses. Not a first-line antihypertensive. ALLHAT discontinued the doxazosin arm early for excess heart failure, making modern guidelines reserve alpha-blockers as fourth/fifth-line agents for resistant HTN.

Other indications: PTSD nightmares (off-label): 1 mg at bedtime initially, titrating by 1 mg every 3-5 days to clinical effect. Typical effective dose 2-10 mg at bedtime; some patients require 15-20 mg. Evidence base: Raskind and Peskind RCTs (2003-2013) showed significant reduction in nightmare frequency and improvement in sleep architecture, though the larger 2018 PACT trial was negative — enthusiasm tempered but use remains common when CBT-I and trauma-focused psychotherapy are inadequate. Benign prostatic hyperplasia: 1-2 mg two or three times daily; extended-release prazosin (XL) is generally preferred for BPH. Raynaud phenomenon: 1-5 mg two or three times daily off-label.

Administration: take with or without food. First dose at bedtime. Regular doses spread 6-8 hours apart.

Monitoring schedule:

• Baseline: supine and standing BP (document postural drop), heart rate, symptom review for dizziness/falls, medication list (check for interacting agents).
• Week 1-2: repeat BP (supine and standing), heart rate, symptom review. Adjust dose up or down based on BP and tolerability.
• Week 4-6: assess target BP; symptom burden; check for BPH symptom response if applicable (IPSS).
• Ongoing: annual BP review, fall/syncope history, cataract history (floppy iris pre-op alert).
• Stop or dose-reduce on: syncope, falls, priapism, floppy iris identification, severe retrograde ejaculation affecting quality of life.

Discontinuation: no rebound syndrome. Alpha-blockers can be stopped but expect some BP rise if they contributed meaningfully to control. Re-initiate at the starting dose (not the previous maintenance dose) if restarting after a gap of >1 week — the first-dose phenomenon returns.

Practical Considerations for Prazopress

• “First-dose phenomenon” — severe orthostatic hypotension, syncope, and reflex tachycardia within 30-90 minutes of the first dose, especially in volume-depleted patients or those already on a diuretic or beta-blocker. Always start 0.5-1 mg at bedtime. Risk diminishes rapidly over the first week as autonomic tone adjusts.
• “Floppy iris syndrome” (intraoperative during cataract surgery) — inform the ophthalmologist of any alpha-blocker history. Can cause iris prolapse and pupillary miosis mid-operation. Does not resolve quickly on stopping the drug.
• Tolerance to the antihypertensive effect can develop over months — partly why alpha-blockers fell out of favour as HTN monotherapy.
• Alcohol potentiates orthostatic hypotension sharply — warn patients especially on initiation.

Side Effects

Common (>1%):

• Orthostatic hypotension and dizziness (especially on standing or after warm showers)
• Fatigue, somnolence
• Headache
• Palpitations (reflex tachycardia)
• Nasal congestion (alpha-blockade of nasal vasculature)
• Nausea, dry mouth
• Urinary incontinence in women (rare; alpha-blockade of bladder-neck tone)
• Priapism — rare but emergent. Seek urgent care for erection >4 hours.
• Peripheral oedema

Uncommon but clinically important:

• Syncope with loss of consciousness on first dose or rapid titration — dose at bedtime; warn the patient explicitly.
• Priapism — emergent urological referral for erection >4 hours.
• Intraoperative floppy iris syndrome — may cause cataract-surgery complications; alert the ophthalmologist.
• Paradoxical urinary incontinence in women (rare; alpha-blockade of bladder-neck tone).
• Worsening of heart failure — class concern from ALLHAT; caution in HF patients.
• Severe hypotension with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — maintain a 4-6 hour gap.

Contraindications

• Known hypersensitivity to quinazolines (prazosin, doxazosin, terazosin)
• Concurrent PDE-5 inhibitor use (sildenafil, tadalafil, vardenafil) without a strict 4-6 hour gap — additive severe hypotension
• History of orthostatic hypotension, syncope, or severe postural BP drop
• Severe aortic stenosis or significant obstructive valvular lesion
• Pregnancy and breastfeeding (limited data; prefer methyldopa or labetalol)

Pregnancy: avoided — limited pregnancy data for alpha-blockers. Switch to methyldopa, labetalol, or nifedipine for pregnancy hypertension.

Breastfeeding: limited data; use with caution. Switch to an agent with better breastfeeding data (labetalol, nifedipine, enalapril) where possible.

Drug Interactions

• PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — CRITICAL. Combined use causes severe additive hypotension. Maintain a 4-6 hour gap between alpha-blocker and PDE-5 inhibitor doses; daily-dose tadalafil 5 mg for BPH is contraindicated with alpha-blockers.
• Other antihypertensives — additive BP-lowering. Start low, titrate slowly.
• Beta-blockers — reduced reflex tachycardia can mask hypoglycaemia or acute bleed. Combined use is not contraindicated but may require lower alpha-blocker starting dose.
• Non-dihydropyridine CCBs (verapamil, diltiazem) — additive hypotension.
• Diuretics — volume depletion potentiates first-dose hypotension. Hold diuretic the day of first alpha-blocker dose if possible.
• Tricyclic antidepressants — additive orthostatic hypotension.
• NSAIDs — reduce antihypertensive effect (less than with thiazides/ACEi).
• Alcohol — marked additive orthostatic hypotension; warn patients.

Where Prazopress Fits in the Antihypertensive Hierarchy

Storage

Store Prazopress below 25°C in the original blister pack. Keep out of reach of children.

Frequently Asked Questions

Why is Prazopress not a first-line blood-pressure drug?

The ALLHAT trial stopped its doxazosin arm three years early after finding a 25% excess of heart failure compared with chlorthalidone. The finding was interpreted as an alpha-blocker class concern. Guidelines now place ACE inhibitors, ARBs, calcium-channel blockers, and thiazides as first-line, reserving alpha-blockers as fourth or fifth-line agents. Alpha-blockers remain preferred add-ons where benign prostatic hyperplasia (BPH) coexists with hypertension — one drug for two problems.

What is the “first-dose phenomenon” and how do I avoid it?

The first dose of any alpha-blocker can cause severe orthostatic hypotension — blood pressure drops on standing, sometimes to the point of syncope, within 30-90 minutes of the dose. Risk is highest in volume-depleted patients (those already on diuretics) or those on beta-blockers. To minimise risk: take the first dose at bedtime, stay in bed for the first 2-3 hours, avoid alcohol, hold the diuretic dose if possible on day 1, and titrate doses weekly rather than daily. The risk falls sharply over the first 7-10 days as autonomic adaptation occurs.

Can I take Prazopress with alcohol?

Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension of Prazopress — falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.

Does prazosin really help PTSD nightmares?

For many patients, yes — but not universally. The evidence base (Raskind and Peskind RCTs, 2003-2013) showed significant reductions in nightmare frequency and improvements in sleep architecture at doses of 2-10 mg at bedtime. The larger PACT trial in 2018 was negative overall, tempering enthusiasm, and current VA/DOD guidance is more cautious than it was in 2015. Many PTSD specialists still use prazosin for distressing trauma-related nightmares when trauma-focused psychotherapy and first-line SSRIs are inadequate. Start 1 mg at bedtime; titrate by 1 mg every 3-5 days to clinical effect; typical effective dose 2-10 mg at bedtime.

What if I miss a dose?

Take it as soon as you remember, unless it is nearly time for your next dose — in that case skip the missed dose and resume at the next scheduled time. Do not double up. A single missed dose does not materially affect long-term BP control.

Can I stop Prazopress if my BP is under control?

Alpha-blockers can be stopped without a dedicated tapering protocol, but BP will usually rise if they contributed meaningfully to control. If restarting after a gap of more than 1 week, re-initiate at the starting dose (not the previous maintenance dose) — the first-dose phenomenon returns after a drug-free break.

Can I take Prazopress in pregnancy?

Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine — Prazopress is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.

Where can I buy Prazopress online?

You can buy Prazopress (1 mg prazosin, 30-90 tablets) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

• Aldactone — Spironolactone 25/50/100 mg (PATHWAY-2 4th-line)
• Amlode — Amlodipine 5/10 mg (CCB)
• Clodict — Clonidine 100 mcg
• Minipress XL — Prazosin ER 2.5/5 mg (Pfizer)
• Prazopress XL — Prazosin ER 2.5/5 mg (Sun Pharma)
• Telma H — Telmisartan + HCTZ combination
• Browse all High Blood Pressure Medications

More options in High Blood Pressure Medication

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Telmaheal

US$9.00 – US$36.00価格帯: US$9.00～US$36.00

Losar

US$6.53 – US$29.25価格帯: US$6.53～US$29.25

Amlode

US$5.50 – US$24.00価格帯: US$5.50～US$24.00

Minoxytop

US$22.00 – US$170.00価格帯: US$22.00～US$170.00